Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 17.8.2020 | EN | Official Journal of the European Union | C 271/36 |

---

Judgment of the General Court of 25 June 2020 — Nitto Pharmaceutical Industries v EUIPO — Chiesi Farmaceutici (NOSTER)

(Case T-550/19) [(1)](#ntr1-C_2020271EN.01003602-E0001)

(EU trade mark - Opposition proceedings - International registration designating the European Union - Word mark NOSTER - Earlier EU word mark FOSTER - Relative ground for refusal - Article 8(1)(b) of Regulation (EU) 2017/1001)

(2020/C 271/46)

Language of the case: English

Parties

Applicant: Nitto Pharmaceutical Industries Ltd (Kyoto, Japan) (represented by: P. Voutilainen, lawyer)

Defendant: European Union Intellectual Property Office (represented by: L. Rampini, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Chiesi Farmaceutici SpA (Parma, Italy) (represented by: C. de Callataÿ and T. de Haan, lawyers)

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 13 May 2019 (Case R 2279/2018-5), relating to opposition proceedings between Chiesi Farmaceutici and Nitto Pharmaceutical Industries.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Nitto Pharmaceutical Industries Ltd to bear its own costs and to pay those incurred by the European Union Intellectual Property Office (EUIPO) and by Chiesi Farmaceutici SpA. |

---

---

[Top](#document1)